Chengfu Xu

机构：Wenzhou Medical University, Zhejiang Taizhou Hospital, Inner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine, Hangzhou Medical College, First Affiliated Hospital Zhejiang University, Zhejiang University · ORCID：0000-0002-6172-1253

发表论文 261 篇 · 总被引 7074 次 · h-index 45

代表论文

• High uric acid exacerbates nonalcoholic steatohepatitis through NLRP3 inflammasome and gasdermin D-mediated pyroptosis (2025 · Journal of Biological Chemistry · 被引 8)
• TJ0113 attenuates fibrosis in metabolic dysfunction-associated steatohepatitis by inducing mitophagy (2025 · International Immunopharmacology · 被引 8)
• The deubiquitinase USP28 maintains the expression of PPARγ and its inactivation protects mice from diet-induced MASH and hepatocarcinoma (2025 · Molecular Therapy · 被引 7)
• 2024 Update of Chinese Guidelines for Management of Hyperuricemia and Gout Part II: Recommendations for Patients With Common Comorbidities (2025 · International Journal of Rheumatic Diseases · 被引 5)
• Remnant cholesterol predicts the development of type 2 diabetes in patients with nonalcoholic fatty liver disease (2025 · Diabetology & Metabolic Syndrome · 被引 5)
• Histidine triad nucleotide-binding protein 2 attenuates metabolic dysfunction-associated steatotic liver disease through NAD+-dependent sirtuin-3 activation (2025 · Experimental & Molecular Medicine · 被引 5)